openPR Logo
Press release

Therapeutic Hypothermia Systems Market Estimated to Flourish By 2025

08-03-2017 04:01 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Therapeutic Hypothermia Systems Market Estimated to Flourish

Therapeutic hypothermia, also known as targeted temperature management or protective hypothermia, is reduction of body temperature, from 32 °C to 34 °C for faster recovery. Therapeutic hypothermia is crucial in the treatment of cardiovascular conditions cardiac arrests and myocardial infarction. Therapeutic hypothermia improves neurological functioning after resuscitation from cardiac arrest. This stabilizes calcium and glutamate levels in the brain cells leading to reduction in cell death. Hence, reduction of body temperature during a surgery is said to increase chances of survival in patients.

Obtain the In-Depth Report Details of Therapeutic Hypothermia Systems Market: http://www.transparencymarketresearch.com/therapeutic-hypothermia-systems-market.html

The global therapeutic hypothermia systems market is anticipated to expand at a significant growth rate in the next few years. Rise in prevalence of cardiovascular diseases is one of the major factors fueling the growth of the global therapeutic hypothermia systems market. According to the American Heart Association, cardiovascular disease account for 2,200 deaths in the U.S. each day. This is likely to drive the global therapeutic hypothermia systems market during the forecast period. Rise in surgeries, prevalence of unhealthy lifestyle, increasing prevalence of neurological conditions, and growing geriatric population are the factors boosting the growth of the global therapeutic hypothermia systems market. Technological advancements leading to higher penetration of devices in many regions are propelling the growth of the global market during the forecast period. Unfavorable regulatory reforms in the U.S., stringent regulatory policies, and high price of the systems are factors expected to restrain the global therapeutic hypothermia market from 2017 to 2025.

The global therapeutic hypothermia systems market can be segmented based on technique, device type, application, end-user, and region. In terms of technique, the market can be categorized into non-invasive and invasive. Based on device type, the global therapeutic hypothermia systems market can be segmented into cooling catheters, water blankets, cool caps, and others. In terms of application, the market can segmented into neurology, cardiology, neonatal care, orthopedics, and others. The cardiology segment is projected to account for the largest market share owing to high prevalence of cardiovascular conditions. Based on end-user, the global market can be categorized into hospitals, emergency units, ambulatory surgical centers, and others. The hospitals segment is expected to account for the largest share in terms of revenue due to growing preference of patients for hospitals than other healthcare providers’ world over.

Geographically, the global therapeutic hypothermia systems market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global therapeutic hypothermia systems market in terms of both revenue and volume. Higher penetration rate, increase in health care expenditure, developed health care infrastructure, and prevalence of unhealthy lifestyle are the major factors likely to drive the therapeutic hypothermia systems market in the region during the forecast period. Asia Pacific is expected to be the fastest growing market for therapeutic hypothermia systems during the forecast period due to factors such as developing health care infrastructure, government initiatives, prevalence of unhealthy lifestyle, and technological advancements.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=27023

Key players in the global therapeutic hypothermia systems market are MTRE Advanced Technologies Ltd., EMCOOLS Medical Cooling Systems GmbH, Koninklijke Philips N.V., and C. R. Bard, Inc., among others.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Therapeutic Hypothermia Systems Market Estimated to Flourish By 2025 here

News-ID: 655046 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Therapeutic

HOME THERAPEUTIC EQUIPMENT INDUSTRY OUTLOOK 2022
The global home therapeutic equipment market is projected to grow from USD 11.06 billion in 2018 to USD XX.XX billion by 2030, at a CAGR of 5.5% during the forecast period. The growth of this market can be attributed to the increasing prevalence of chronic diseases, the rising geriatric population, and the growing demand for home healthcare services. Get free copy of the report 2022: https://www.accuracyreports.com/request/download/12/11431/Global-Home-Therapeutic-Equipment-Industry-Outlook-2022:-Overview-Opportunities-Key-Companies-and-Forecast-to-2028 This report studies the Home Therapeutic
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system
Therapeutic Vaccines Market Insights by Top Players Novartis AG, GlaxoSmithKline …
Vaccine is a biological product that initiates stimulation to antibodies and helps provide immunity against infectious and chronic diseases. There are various types of vaccines such as inactivated vaccines, subunit vaccines, recombinant vector vaccines and DNA vaccines. Vaccines are mainly prophylactic in nature along with therapeutic effect. The wide application of vaccines is expected to favor the therapeutic vaccines market. Therapeutic vaccine is a combination of biologics that is designed
Therapeutic Socks Market
Therapeutic Socks Market Overview Compression therapy is a safe and cost-effective method of treating wounds, vein thrombosis, phlebitis and providing post-surgery care. It relies on a simple yet efficient principle – applying an elastic garment around a limb. A relatively new form of treatment, it is anticipated to post rapid growth during the next decade. Compression therapy includes garments like leggings, shirts, socks and stockings. The therapeutic socks market, otherwise known